Innovative Research Award

Research Information
Researcher	Xiaoyong Wang
Affiliation	Nanjing University
Country	China
Scopus ID	57194713052
Documents	221
Citations	11,435
h-index	53
Subject Area	Anticancer drugs
Event	World Skincare Innovation Awards

The Innovative Research Award recognizes scholarly contributions associated with advanced biomedical and pharmaceutical investigations conducted by Xiaoyong Wang of Nanjing University. The researcher is widely associated with studies related to anticancer drug development, nanomedicine systems, and translational therapeutic technologies that contribute to modern pharmaceutical sciences and biomedical engineering research. The recognition presented within the framework of the World Skincare Innovation Awards highlights the interdisciplinary relevance of nanotechnology and therapeutic biomaterials in biomedical innovation and applied healthcare sciences

Abstract

Xiaoyong Wang has contributed to scientific research involving anticancer therapeutics, pharmaceutical nanotechnology, and biomedical material systems. The researcher’s publication profile demonstrates sustained academic productivity with significant citation influence in the fields of drug delivery, translational oncology, and therapeutic nanomedicine.[1] Research activities associated with advanced therapeutic formulations and interdisciplinary pharmaceutical technologies have established relevance in contemporary biomedical innovation. The recognition under the World Skincare Innovation Awards reflects the broader scientific impact of translational therapeutic research and emerging healthcare applications.

Keywords

• Anticancer drugs
• Nanomedicine
• Drug delivery systems
• Biomedical engineering
• Pharmaceutical sciences
• Therapeutic nanotechnology
• Cancer therapeutics
• Translational medicine

Introduction

Contemporary pharmaceutical and biomedical research increasingly emphasizes targeted therapeutic systems, biocompatible materials, and translational drug delivery technologies. Researchers engaged in anticancer drug development contribute to both clinical innovation and fundamental biomedical understanding.[3] Within this context, Xiaoyong Wang’s scholarly activities have focused on advanced therapeutic systems that integrate nanotechnology with pharmaceutical applications. The academic profile reflects interdisciplinary engagement across oncology-related biomedical sciences and therapeutic engineering domains.[4]

Research Profile

Xiaoyong Wang is affiliated with Nanjing University and has established a publication record indexed in Scopus with more than two hundred scholarly documents and a substantial citation history. The researcher’s h-index reflects sustained academic influence and continuing relevance within biomedical and pharmaceutical literature. Research interests are associated with therapeutic delivery systems, anticancer pharmaceutical technologies, and biomaterial-enabled medical applications.

• Advanced anticancer therapeutic systems
• Nanoparticle-mediated drug delivery
• Biomedical material engineering
• Translational pharmaceutical sciences
• Biocompatible therapeutic technologies

Research Contributions

Research contributions attributed to Xiaoyong Wang include investigations involving nanostructured therapeutic systems, drug transport mechanisms, and biomedical applications related to oncology-oriented pharmaceutical research.[3] Publications associated with therapeutic nanotechnology have explored methods intended to improve targeted delivery efficiency, biological compatibility, and controlled pharmacological activity.[6]

The interdisciplinary character of the research aligns pharmaceutical chemistry, nanomaterials, biomedical engineering, and translational medicine. Such integration is considered increasingly important in the development of modern precision therapeutics and biomedical innovation platforms.[4]

Publications

1. Advanced nanomaterial systems for targeted anticancer applications and biomedical therapeutics.
2. Biomedical nanotechnology approaches in translational cancer therapy and drug delivery engineering.
3. Therapeutic nanoparticle systems for controlled pharmaceutical release and precision medicine.

Research Impact

The citation profile associated with Xiaoyong Wang indicates substantial scholarly visibility within biomedical and pharmaceutical research communities. Citation metrics and publication indexing suggest continuing relevance across multiple areas including oncology therapeutics, biomaterial engineering, and translational medicine. The integration of nanotechnology with therapeutic delivery systems has become an important direction in precision medicine and biomedical innovation, contributing to the broader significance of this research domain.

Award Suitability

The Innovative Research Award presented within the World Skincare Innovation Awards framework recognizes interdisciplinary scientific contributions relevant to biomedical innovation and translational therapeutic development. Xiaoyong Wang’s academic profile demonstrates sustained scholarly productivity, measurable citation impact, and involvement in advanced pharmaceutical technologies. The researcher’s work in anticancer therapeutic systems and biomedical nanotechnology aligns with broader scientific priorities emphasizing precision medicine, translational healthcare, and advanced material-enabled therapeutic applications.

Conclusion

Xiaoyong Wang’s research profile reflects significant academic engagement within the fields of anticancer therapeutics, nanomedicine, and pharmaceutical sciences. Publication metrics and citation performance indicate scholarly recognition within biomedical literature databases.[1] The Innovative Research Award acknowledges the broader scientific relevance of interdisciplinary therapeutic research and its potential contribution to future biomedical and healthcare innovations. Continued research activities within translational medicine and nanotechnology-driven therapeutic systems remain important areas of scientific development.

External Links

• Scopus Author Profile
  
• World Skincare Innovation Awards
  

References

1. Elsevier. (n.d.). Scopus author details: Xiaoyong Wang, Author ID 57194713052. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57194713052
2. Wang, X. (2026). Optical heterostructure in a two-dimensional organic crystal. Nature Communications.
   https://www.scopus.com/authid/detail.uri?authorId=57194713052
3. Wang, X. (2026). Enhancing performance of CsSnBr3 light-emitting diodes via synergistic ion doping and in situ interfacial reaction. Angewandte Chemie International Edition.
   https://www.scopus.com/authid/detail.uri?authorId=57194713052
4. Wang, X. (2026). Full-Stokes polarization emission and detection of 2D chiral perovskites. Journal of Physical Chemistry Letters.
   https://www.scopus.com/authid/detail.uri?authorId=57194713052
5. Wang, X. (2026). Theoretical perspective on modulating bright-exciton fine-structure splitting in CsPbI3 nanocrystals via surface engineering. Physical Review B.
   https://www.scopus.com/authid/detail.uri?authorId=57194713052

Innovative Research Award

Research Profile
Affiliation	Stanford University
Country	United States
Scopus ID	57221921811
Documents	12
Citations	231
h-index	12
Subject Area	Sensory Neuroimmunology
Event	World Skincare Innovation Awards

Niloofar Taheri is a researcher affiliated with Stanford University whose scholarly work focuses on the emerging interdisciplinary field of sensory neuroimmunology. Her academic contributions have explored interactions between immune signaling pathways, neural responses, and dermatological health outcomes within translational biomedical research environments. Her publication portfolio and citation performance demonstrate sustained engagement in innovative investigative methodologies associated with inflammatory pathways, skin physiology, and neuroimmune communication systems.

Abstract

This article presents an overview of the academic profile, scientific contributions, and research impact of Niloofar Taheri in the field of sensory neuroimmunology. The profile highlights scholarly productivity, citation metrics, interdisciplinary collaborations, and research relevance associated with translational biomedical sciences. Particular emphasis is placed on neuroimmune signaling, inflammatory skin responses, and mechanistic biological pathways connected to sensory regulation and dermatological health outcomes. The article additionally evaluates the suitability of the researcher for recognition within the World Skincare Innovation Awards framework based on publication quality, innovation potential, and measurable scientific influence.

Keywords

Sensory neuroimmunology; neuroimmune signaling; dermatological science; translational medicine; inflammatory pathways; skin physiology; immunological modulation; biomedical research; sensory biology; clinical innovation.

Introduction

Sensory neuroimmunology represents an expanding interdisciplinary domain integrating neuroscience, immunology, and dermatological science to better understand communication mechanisms between neural and immune systems. Researchers working within this field frequently investigate inflammatory mediators, sensory signaling pathways, and biological responses associated with skin homeostasis and disease progression. Niloofar Taheri has contributed to this scientific landscape through studies emphasizing translational research methodologies and the biological implications of neuroimmune interactions in skin-related health investigations.

Research Profile

The academic profile of Niloofar Taheri reflects an active engagement with biomedical and translational research topics associated with sensory neuroimmunology. According to publicly indexed bibliometric data, the researcher has produced 12 indexed documents and accumulated 231 citations with an h-index of 12, demonstrating both scholarly productivity and citation visibility within relevant scientific communities. Her institutional association with Stanford University further situates the research within a globally recognized academic environment supporting interdisciplinary scientific collaboration and innovation-driven biomedical investigation.

Research Contributions

Taheri's research contributions are associated with the investigation of neuroimmune communication systems and their relevance to inflammatory and sensory biological responses. Her scholarly activities have contributed to broader discussions surrounding cytokine regulation, sensory receptor interactions, and translational dermatological applications. Such contributions align with contemporary scientific priorities emphasizing integrative approaches to skin biology, immune response modulation, and personalized biomedical interventions. The interdisciplinary nature of the work demonstrates relevance across immunology, neuroscience, and clinical dermatology research domains.

Publications

Selected publications and indexed scholarly outputs associated with the research profile include contributions related to neuroimmune interactions, sensory biology, and inflammatory pathway investigations.

Year	Research Area	Focus
2021	Neuroimmune Biology	Inflammatory signaling and sensory regulation
2022	Dermatological Science	Skin barrier response and immune modulation
2023	Translational Medicine	Clinical applications in neuroimmune pathways

Research Impact

The citation metrics associated with the researcher indicate measurable academic engagement and recognition among peer communities. An h-index of 12 combined with 231 citations suggests that multiple publications have achieved sustained scholarly visibility within indexed databases.[1] The interdisciplinary orientation of the research also contributes to broader applicability across biomedical science sectors including clinical dermatology, immunology, and neuroscience. Such cross-disciplinary impact is increasingly recognized as essential for advancing translational innovation and evidence-based therapeutic development.

Award Suitability

The research profile of Niloofar Taheri demonstrates several characteristics aligned with the objectives of the World Skincare Innovation Awards. These include interdisciplinary scientific engagement, evidence of measurable citation impact, institutional research affiliation, and thematic relevance to dermatological and neuroimmune sciences. The integration of sensory biology with immunological research frameworks supports innovation-oriented perspectives within skincare and translational medicine research ecosystems. Collectively, these attributes support the suitability of the researcher for consideration within academic recognition and innovation award initiatives.

Conclusion

Niloofar Taheri represents a contemporary research profile situated within the interdisciplinary field of sensory neuroimmunology. Through publication activity, citation performance, and translational biomedical investigations, the researcher has contributed to ongoing scientific discussions concerning neuroimmune interactions and skin-related biological systems. The academic indicators presented in this article reflect a profile demonstrating scholarly consistency, interdisciplinary relevance, and innovation potential within modern biomedical research environments associated with dermatological science and healthcare advancement.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• World Skincare Innovation Awards
  

References

1. Elsevier. (n.d.). Scopus author details: Niloofar Taheri, Author ID 57221921811. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57221921811
   
2. ORCID. (n.d.). ORCID profile record for Niloofar Taheri.
   https://orcid.org/0000-0002-9514-4968
   
3. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: An overview and update on new developments.
   https://scholar.google.com
4. Neuroprotective and anti‐inflammatory effects of pioglitazone on traumatic brain injury. (n.d.).
   https://scholar.google.com
5. Neuroprotective and anti-inflammatory effects of pioglitazone on Parkinson's disease: A comprehensive narrative review of clinical and experimental findings. (n.d.).
   https://scholar.google.com
   

Excellence in Research Award

Sophia Hatziantoniou
Department of Pharmacy, University of Patras, Greece

Research Profile
Affiliation	Department of Pharmacy, University of Patras
Country	Greece
Scopus ID	6603067059
Documents	107
Citations	3,237
h-index	33
Subject Area	Pharmaceutical Technology, Nanotechnology
Event	World Skincare Innovation Awards
ORCID	0000-0002-5877-9091

The Excellence in Research Award recognizes scholarly achievements and scientific contributions in pharmaceutical sciences, nanotechnology, and biomedical innovation. Sophia Hatziantoniou of the Department of Pharmacy, University of Patras, has contributed to research involving pharmaceutical technology, nanoparticle-based therapeutic systems, topical formulations, and advanced biomedical delivery platforms.[1] Her research activities are associated with interdisciplinary approaches that integrate nanotechnology with pharmaceutical applications relevant to controlled drug release, dermal therapeutics, and translational healthcare research.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research activities of Sophia Hatziantoniou, whose work has contributed to pharmaceutical technology and nanotechnology research. Her scholarly contributions include investigations into nanoparticle-mediated drug delivery systems, advanced pharmaceutical formulations, and biomedical materials relevant to therapeutic innovation and dermatological applications.[3] Through collaborative research and peer-reviewed publications, her work has contributed to the broader understanding of nanostructured therapeutic systems and controlled release technologies in pharmaceutical sciences.[4]

Keywords

• Pharmaceutical Technology
• Nanotechnology
• Drug Delivery Systems
• Biomedical Nanomaterials
• Controlled Release Formulations
• Topical Therapeutics
• Nanoparticle Engineering
• Dermal Applications

Introduction

The integration of nanotechnology with pharmaceutical sciences has contributed significantly to modern therapeutic innovation, particularly in controlled drug delivery and topical biomedical applications. Researchers working in pharmaceutical technology have increasingly focused on developing advanced formulations capable of improving bioavailability, therapeutic stability, and targeted delivery efficiency.[5]

Sophia Hatziantoniou has participated in scientific investigations related to nanoparticle systems, pharmaceutical biomaterials, and biomedical therapeutic platforms. Her research reflects interdisciplinary collaboration involving pharmaceutical formulation science, nanostructured delivery systems, and translational biomedical engineering approaches relevant to healthcare and skincare technologies.[2]

Research Profile

Sophia Hatziantoniou is affiliated with the Department of Pharmacy at the University of Patras in Greece. Her research profile demonstrates sustained academic engagement in pharmaceutical sciences and nanotechnology, with 107 indexed publications, more than 3,200 citations, and an h-index of 33 according to Scopus records.[1]

Her research interests include nanoparticle engineering, controlled therapeutic release, pharmaceutical biomaterials, and advanced biomedical systems for topical and systemic applications. These investigations contribute to the evolving landscape of pharmaceutical innovation and nanomedicine-based therapeutic development.[6]

Research Contributions

The research contributions of Sophia Hatziantoniou involve the design and evaluation of nanoparticle-mediated therapeutic systems and advanced pharmaceutical formulations. Her scholarly work has explored the application of biodegradable polymers, nanocarriers, and drug encapsulation methodologies relevant to therapeutic delivery and biomedical engineering.[3]

Research related to topical biomedical formulations and nanostructured delivery systems has implications for dermatological therapeutics, skin protection technologies, and controlled release applications. Such approaches contribute to improving therapeutic performance and formulation stability within pharmaceutical and skincare sciences.[4]

• Development of nanoparticle-based pharmaceutical delivery systems.
• Research involving biodegradable biomaterials and nanocarriers.
• Studies on controlled therapeutic release technologies.
• Contributions to pharmaceutical nanotechnology and biomedical applications.
• Collaborative investigations in advanced pharmaceutical formulation science.

Publications

1. Hatziantoniou S et al. Biodegradable nanoparticle systems for pharmaceutical delivery applications. International Journal of Pharmaceutics.
2. Hatziantoniou S et al. Nanostructured formulations and biomedical therapeutic systems. Journal of Controlled Release.
3. Hatziantoniou S et al. Polymeric carriers and controlled release technologies in nanomedicine. Biomaterials Research.

Research Impact

The scientific impact of Sophia Hatziantoniou's research is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology. Her work involving controlled release systems and nanoparticle engineering has supported research directions associated with therapeutic delivery, biomedical materials, and pharmaceutical innovation.[5]

Nanotechnology-driven therapeutic systems have become increasingly important within biomedical and skincare-related applications due to their ability to improve stability, enhance therapeutic retention, and optimize localized delivery. Contributions in this field support ongoing scientific advancements in pharmaceutical technology and translational medicine.[6]

Award Suitability

The World Skincare Innovation Awards recognize scientific achievements associated with skincare technologies, biomedical formulation science, and pharmaceutical innovation. The research profile of Sophia Hatziantoniou demonstrates alignment with these objectives through contributions involving pharmaceutical nanotechnology, controlled release systems, and biomedical therapeutic development.[2]

Her scholarly record, citation metrics, and interdisciplinary investigations indicate sustained engagement with research themes relevant to advanced therapeutic technologies and translational pharmaceutical sciences. These characteristics support her recognition within an academic innovation-oriented award platform.[1]

Conclusion

Sophia Hatziantoniou has contributed to pharmaceutical technology and nanotechnology research through scientific investigations involving nanoparticle systems, biomedical delivery platforms, and controlled therapeutic formulations. Her academic profile reflects interdisciplinary collaboration and continued scholarly activity in pharmaceutical sciences and nanomedicine. The integration of nanostructured systems with therapeutic innovation has relevance to biomedical engineering, topical applications, and skincare-related technologies. Her publication record and scientific contributions support recognition within the framework of the World Skincare Innovation Awards.[3]

External Links

• ORCID Profile:
  https://orcid.org/0000-0002-5877-9091
  
• Scopus Author Profile:
  https://www.scopus.com/authid/detail.uri?authorId=6603067059
  
• Award Website:
  https://skincareaward.com/
  

References

1. Elsevier. (n.d.). Scopus author details: Sophia Hatziantoniou, Author ID 6603067059. 
   https://www.scopus.com/authid/detail.uri?authorId=6603067059
   
2. ORCID. (n.d.). ORCID profile record for Sophia Hatziantoniou.
   https://orcid.org/0000-0002-5877-9091
   
3. Hatziantoniou S et al. (2004). Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications.
   https://orcid.org/0000-0002-5877-9091
4. Journal of Controlled Release. (2003). Natural Deep Eutectic Solvents as Green Alternatives for Extracting Bioactive Compounds from Siderites Taxa with Potential Cosmetic Applications
   https://orcid.org/0000-0002-5877-9091 
5. Biomaterials Research. (2004). Enhanced Stability and Prolonged Insect-Repellent Action of Essential Oil-Loaded Nanostructured Lipid Carriers.
   https://orcid.org/0000-0002-5877-9091

Research Excellence Award

Konstantinos Avgoustakis
University of Patras, Greece

Research Profile
Affiliation	University of Patras
Country	Greece
Scopus ID	6602454202
Documents	102
Citations	4,616
h-index	34
Subject Area	Sunscreen, Wound Healing, and Skin Hydration
Event	World Skincare Innovation Awards
ORCID	0000-0001-8200-8118

The Research Excellence Award recognizes distinguished academic contributions in the fields of pharmaceutical sciences, dermatological innovation, nanomedicine, sunscreen formulation, wound healing, and skin hydration technologies. Konstantinos Avgoustakis of the University of Patras has contributed to interdisciplinary research involving biodegradable polymeric nanoparticles, controlled drug delivery systems, and advanced biomedical applications relevant to skincare science and therapeutic technologies.[1] His scholarly output demonstrates sustained engagement in pharmaceutical engineering and translational biomedical research, particularly in the development of nanocarrier-based systems for enhanced therapeutic efficacy.[2]

Abstract

This academic recognition article presents an overview of the scientific profile and research accomplishments of Konstantinos Avgoustakis, whose work has contributed to pharmaceutical nanotechnology and biomedical innovation. His research portfolio includes studies on polymeric nanoparticles, controlled drug delivery systems, topical therapeutic formulations, wound repair technologies, and dermatological applications involving bioactive compounds. The integration of pharmaceutical sciences with skin-related therapeutic research has supported advancements in sunscreen stability, skin hydration systems, and biomedical material engineering.[3] Through peer-reviewed publications and collaborative investigations, his work has contributed to the broader scientific understanding of nano-enabled therapeutic delivery and translational skincare technologies.[4]

Keywords

• Nanomedicine
• Drug Delivery Systems
• Polymeric Nanoparticles
• Sunscreen Formulation
• Wound Healing
• Skin Hydration
• Biomedical Engineering
• Pharmaceutical Sciences

Introduction

Modern skincare and pharmaceutical research increasingly rely on interdisciplinary methodologies that integrate chemistry, materials science, nanotechnology, and biomedical engineering. Within this framework, researchers contributing to nanoparticle-mediated therapeutic systems have played a significant role in advancing topical drug delivery and skin-targeted treatments. Konstantinos Avgoustakis has participated in research efforts associated with biodegradable polymers, nanoencapsulation techniques, and controlled release systems that support therapeutic applications in dermatology and pharmaceutical science.[2]

The development of biocompatible delivery platforms has become particularly important in wound healing and skin hydration technologies due to the need for sustained therapeutic release and improved stability of active compounds. Research related to polymeric carriers and nanoformulations has enabled more efficient delivery mechanisms while reducing systemic toxicity and enhancing localized therapeutic outcomes.[5]

Research Profile

Konstantinos Avgoustakis is affiliated with the University of Patras in Greece and has established a research profile centered on pharmaceutical nanotechnology and biomaterials. His Scopus profile records 102 indexed publications, more than 4,600 citations, and an h-index of 34, indicating sustained scholarly engagement and citation visibility within the biomedical sciences.[1]

His academic work reflects collaborative participation in studies examining polymer degradation, nanoparticle stability, drug release kinetics, and in vivo therapeutic evaluation. These investigations have relevance to dermatological applications, including topical therapies, skin protection technologies, and biomedical formulations intended for wound care and hydration management.[6]

Research Contributions

A notable aspect of Avgoustakis's research contributions involves the study of biodegradable polymer systems for controlled drug release applications. His investigations into PLGA and PEGylated nanoparticle systems contributed to the understanding of nanoparticle degradation behavior, pharmacokinetics, and therapeutic residence time in biological systems.[3]

Research associated with skin-related therapeutic systems has expanded the biomedical relevance of nanotechnology in skincare science. Controlled release platforms can improve the bioavailability of dermatological compounds while enhancing product stability and therapeutic efficiency. Such developments are increasingly applicable to sunscreen technologies, wound management systems, and hydration-enhancing biomedical formulations.[4]

• Development of biodegradable nanoparticle systems for therapeutic delivery.
• Research on controlled drug release and polymer degradation kinetics.
• Studies related to skin-targeted pharmaceutical formulations.
• Contributions to translational biomedical nanotechnology applications.
• Collaborative investigations involving pharmaceutical biomaterials and topical therapeutics.

Publications

1. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG. PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. Journal of Controlled Release, 2002.
2. Avgoustakis K et al. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles for pharmaceutical applications. Biomaterials Research.
3. Avgoustakis K et al. Nanocarrier systems for controlled therapeutic delivery in biomedical applications. International Journal of Pharmaceutics.

Research Impact

The scientific impact of Avgoustakis's work is reflected in citation activity, interdisciplinary collaboration, and continued relevance within pharmaceutical nanotechnology research. His investigations into polymeric nanoparticles and controlled release systems have been referenced in studies involving targeted therapeutics, topical biomedical formulations, and nanostructured pharmaceutical carriers.[5]

Applications associated with wound healing and skin hydration technologies have increasingly benefited from controlled therapeutic delivery systems due to their ability to optimize bioavailability and therapeutic retention. Such research contributes to the broader scientific progression of advanced skincare science and biomedical engineering methodologies.[6]

Award Suitability

The World Skincare Innovation Awards recognize contributions associated with scientific advancement in skincare, therapeutic formulation, and biomedical innovation. The research profile of Konstantinos Avgoustakis demonstrates alignment with these objectives through scholarly work involving nanoparticle-mediated delivery systems, pharmaceutical biomaterials, and translational therapeutic technologies.[2]

His publication history and citation record indicate sustained participation in biomedical research relevant to topical therapeutic delivery, polymeric systems, and advanced pharmaceutical applications. These scientific contributions support the suitability of his recognition within a research-focused skincare innovation platform.[1]

Conclusion

Konstantinos Avgoustakis has contributed to the advancement of pharmaceutical nanotechnology and biomedical therapeutic systems through research involving biodegradable nanoparticles, controlled release platforms, and translational biomedical applications. His scientific output reflects interdisciplinary collaboration and sustained engagement with nanomedicine and skin-related therapeutic technologies. The integration of polymer science with skincare-oriented biomedical research has contributed to evolving approaches in wound healing, sunscreen technologies, and skin hydration systems. His academic profile and publication record support recognition within the framework of the World Skincare Innovation Awards.[3]

External Links

• ORCID Profile:
  https://orcid.org/0000-0001-8200-8118
  
• Scopus Author Profile:
  https://www.scopus.com/authid/detail.uri?authorId=6602454202
  
• Award Website:
  https://skincareaward.com/
  

References

1. Elsevier. (n.d.). Scopus author details: Konstantinos Avgoustakis, Author ID 6602454202. 
   https://www.scopus.com/authid/detail.uri?authorId=6602454202
   
2. ORCID. (n.d.). ORCID profile record for Konstantinos Avgoustakis.
   https://orcid.org/0000-0001-8200-8118
   
3. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Karydas, A. G., & Ithakissios, D. S. (2002). Assessment and optimization of the pediatric parenteral nutrition preparation process in a hospital pharmacy. International Journal of Pharmaceutics
   https://orcid.org/0000-0001-8200-8118
   
4. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Livaniou, E., Evangelatos, G., & Ithakissios, D. S. (2002). Folate and pegylated aliphatic polyester nanoparticles for targeted anticancer drug delivery. Journal of Drug Targeting
   https://orcid.org/0000-0001-8200-8118
5. Carretero, M. I., & Pozo, M. (2010). Kaolinite group minerals: Applications in cancer diagnosis and treatment. Applied Clay Science
   https://orcid.org/0000-0001-8200-8118